Primary care experience on Stimunex® gocce in children with recurrent respiratory infections: a real-world study during the COVID-19 pandemic era

Main Article Content

Alessandro Giannattasio
Elena Poggi
Gianfranco Trapani
Cosimo Muia
Luisella Zanino
Massimo Landi
Giorgio Ciprandi

Keywords

recurrent respiratory infection, immune system, Sambucus nigra, β-glucan Zinc, Vitamin D, children, real-world, primary care

Abstract

Background: Respiratory infections (RI) significantly burden society, mainly when there are recurrent respiratory infections (RRI). Thus, there is a need to prevent RI in clinical practice. In this regard, the modulation of the immune system and resolution of the inflammatory cascade could represent an ideal way to prevent RI. Stimunex® gocce, a multicomponent food supplement, contains Sambucus nigra extract, β-glucan, Zinc, and Vitamin D3. This study investigated its ability to prevent RRI in children using a real-world setting: the pediatric primary care.


Materials and methods: Two hundred and ninety-eight children with RRI were enrolled in the current study. The food supplement was randomly prescribed to 160 children with RRI daily for 4 months (Active group); the remaining 138 children with RRI were treated only with standard therapy for RI (Control group). The number and duration of RI, parental perception of symptom severity and treatment efficacy, use of medications, and school and working absence were evaluated.


Results: Children treated with Stimunex® gocce had significantly less RI than the Control group, both concerning upper and lower RI (p˂0.001 and 0.003, respectively) during the follow-up period. Moreover, children in the Active group experienced shorter RI duration during the treatment and follow-up phases (p˂0.001 for both). In addition, parents of treated children perceived less severe symptoms and better treatment efficacy during the first and follow-up phases (p˂0.001 for all). The food supplement was well tolerated and there was no adverse event.


Conclusions: The current real-world study demonstrated that Stimunex® gocce supplementation in children with RRI might safely prevent RI episodes and reduce RI duration. These outcomes should be highlighted as obtained during the COVID-19 pandemic era, characterized by a dramatic reduction of RI.

Abstract 118 | PDF Downloads 78 HTML Downloads 78 XML Downloads 4

References

1. Chiappini E, Cutrera R, Galli L, Marchisio P, Marseglia GL, Santamaria F. La prevenzione delle infezioni respiratorie ricorrenti. Area Pediatr. 2021;22:68–78.

2. Ciprandi G, Tosca MA, Fasce L. Allergic children have more numerous and severe respiratory infections than non-allergic children. Pediatr Allergy Immunol. 2006;17:389–391. 10.1111/j.1399-3038.2006.00413.x

3. Ciprandi G, Marseglia GL, Klersy C, Tosca MA. Relationships between allergic inflammation and nasal airflow in children with persistent allergic rhinitis due to mite sensitization. Allergy. 2005;60:957–960. 10.1111/j.1398-9995.2005.00664.x

4. Li J, Song X, Yang T, Chen Y, Gong Y, Yin X, et al. A systematic review of antibiotic prescription associated with upper respiratory tract infections in China. Medicine (Baltimore). 2016;95(19):e3587. 10.1097/MD.0000000000003587

5. Varricchio A, La Mantia I, Brunese FP, Ciprandi G. Inflammation, infection, and allergy of upper airways: New insights from national and real-world studies. Italian J Pediatr. 2020;46:18. 10.1186/s13052-020-0782-z

6. Fürst R, Zündorf I. Plant-derived anti-inflammatory compounds: Hopes and disappointments regarding the translation of preclinical knowledge into clinical progress. Mediators Inflamm. 2014;2014:146832. 10.1155/2014/146832

7. Atkinson MD, Atkinson E. Sambucus nigra. J Ecol. 2002;90:895–923. 10.1046/j.1365-2745.2002.00698.x

8. Scopel M, Mentz LA, Henriques AT. Comparative analysis of Sambucus nigra and Sambucus australis flowers: Development and validation of an HPLC method for raw material quantification and preliminary stability study. Planta Med. 2010;76:1026–1031. 10.1055/s-0029-1240850

9. Benevides Bahiense J, Marques FM, Figueira MM, Vargas TS, Kondratyuk TP, Endringer DC, et al. Potential anti-inflammatory, antioxidant and antimicrobial activities of Sambucus australis. Pharm Biol. 2017;55:991–997. 10.1080/13880209.2017.1285324

10. Harokopakis E, Albzreh MH, Haase EM, Scannapieco FA, Hajishengallis G. Inhibition of proinflammatory activities of major periodontal pathogens by aqueous extracts from elder flower (Sambucus nigra). J Periodontol. 2006;77:271–279. 10.1902/jop.2006.050232

11. Balkan IA, Ilter Akülke AZ, Bagatur Y, Telci D, Goren AC, Kırmızıbekmez H, et al. Sambulin A and B, non-glycosidic iridoids from Sambucus ebulus, exert significant in vitro anti-inflammatory activity in LPS-induced RAW 264. 7 macrophages via inhibition of MAPKs’s phosphorylation.J Ethnopharmacol. 2017;206:347–352. 10.1016/j.jep.2017.06.002

12. Lin P, Hwang E, Ngo HTT, Seo SA, Yi TH. Sambucus nigra L. ameliorates UVB-induced photoaging and inflammatory response in human skin keratinocytes. Cytotechnology. 2019;71:1003–1017. 10.1007/s10616-019-00342-1

13. Carneiro NVQ, Silva HBFD, Silva RRD, Carneiro TCB, Costa RS, Pires AO, et al. Sambucus australis modulates inflammatory response via inhibition of nuclear factor kappa B (NF-kB) in vitro. An Acad Bras Cienc. 2019;91:e20170831. 10.1590/0001-3765201920170831

14. Vetvicka V, Vannucci L, Sima P, Richter J. Beta glucan: Supplement or drug? From laboratory to clinical trials. Molecules. 2019;24:7. 10.3390/molecules24071251

15. Rahar S, Swami G, Nagpal N, Nagpal MA, Singh GS. Preparation, characterization, and biological properties of β-glucans. J Adv Pharm Technol Res. 2011;2:94–103. 10.4103/2231-4040.82953

16. Holick MF. Vitamin D deficiency. New Engl J Med. 2007;357:266–281. 10.1056/NEJMra070553

17. Saggese G, Vierucci F. Il rachitismo carenziale. Area Pediatrica. 2010;3:22–28.

18. Camargo CA Jr, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ, et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Paediatrics. 2011;127:180–187. 10.1542/peds.2010-0442

19. Saggese G. Vitamin D in pediatric age: Consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians. Italian J Pediatri. 2018;44:51. 10.1186/s13052-018-0488-7

20. Wessels I, Fischer HJ, Rink L. Dietary and physiological effects of zinc on the immune system. Annu Rev Nutr. 2021; 41:133–175. 10.1146/annurev-nutr-122019-120635

21. Aguzzi C, Marinelli O, Zeppa L, Santoni G, Maggi F, Nabissi M. Evaluation of anti-inflammatory and immunoregulatory activities of Stimunex® and Stimunex D3® in human monocytes/macrophages stimulated with LPS or IL-4/IL-13. Biomed Pharmacother. 2020;132:110845. 10.1016/j.biopha.2020.110845

22. Ameli F, Ciprandi G. Sinerga may prevent recurrent respiratory infections in allergic children. J Biol Reg. 2019; 33:601–607.

23. Barberi S, D’Auria E, Bernardo L, Pinto F, Pietra B, Ciprandi G. Hypertonic saline monotherapy in children with perennial allergic rhinitis: A pilot study. J Biol Res. 2016;30:271–275.

24. Burg AR, Quigley L, Jones AV, O’Connor GM, Boelte K, McVicar DW, et al. Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity. Springerplus. 2016;5:815. 10.1186/s40064-016-2501-1

25. Engstad CS, Engstad RE, Olsen JO, Osterud B. The effect of soluble beta-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int Immunopharmacol. 2002;2:1585–1597. 10.1016/S1567-5769(02)00134-0

26. Wu S, Yoon S, Zhang YG, Lu R, Xia Y, Wan J, et al. Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol Gastrointest Liver Physiol. 2015;309:G341–G349. 10.1152/ajpgi.00105.2015

27. Choi KYG, Napper S, Mookherjee N. Human cathelicidin LL-37 and its derivative IL-19 regulate interleukin-32-induced inflammation. Immunology. 2014;142:68–80. 10.1111/imm.12291

28. Gammoh NZ, Rink L. Zinc in infection and inflammation. Nutrients. 2017;9:624. 10.3390/nu9060624

29. Guedj R, Lorrot M, Lecarpentier T, Leger PL, Corvol H, Carbajal R. Infant bronchiolitis dramatically reduced during the second French COVID-19outbreak. Acta Paediatr. 2021;110:1297–1299. 10.1111/apa.15780

30. Iozzi L, Brambilla I, Foiadelli T, Marseglia GL, Ciprandi G. Paediatric emergency department visits fell by more than 70% during the COVID-19 lockdown in Northern Italy. Acta Pediatr 2020;109:2137–2138. 10.1111/apa.15458

31. Poggi E, Giannattasio A, Cartosio E, Campus R, Ciprandi G. Primary care experience on Rinfodim 3® in children with recurrent respiratory infections. J Biol Regul Homeost Agents. 2020;34:2365–2373.

32. Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence—What is it and what can it tell us? N Engl J Med. 2016;375:2293–2297. 10.1056/NEJMsb1609216